What Did This CEO Just Do with Personal Shares of Amphastar Pharmaceuticals (NASDAQ: AMPH)?

By Carrie Williams

Yesterday, the CEO & Chief Scientific Officer of Amphastar Pharmaceuticals (NASDAQ: AMPH), Jack Zhang, sold shares of AMPH for $6.09M.

Following Jack Zhang’s last AMPH Sell transaction on September 15, 2017, the stock climbed by 2.0%.

The company has a one-year high of $21.75 and a one-year low of $12.05. AMPH’s market cap is $815.1M and the company has a P/E ratio of 4933.33. Currently, Amphastar Pharmaceuticals has an average volume of 17.22K.

Based on 5 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $20.75, reflecting a -14.7% downside.

The insider sentiment on Amphastar Pharmaceuticals has been negative according to 54 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Jack Zhang’s trades have generated a 7.4% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.